Security record · archived quarter
LNTH
Lantheus Holdings, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
14Tracked holders
—Δ holders
5.72MShares held
$459.02MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 129 | +5 | 56.22M | $5.58B | +13 | −7 |
| Q1 2026 | 126 | +6 | 62.19M | $3.90B | +10 | −5 |
| Q4 2025 | 120 | -2 | 60.97M | $3.47B | +2 | −3 |
| Q3 2025 | 20 | +2 | 33.16M | $1.70B | +2 | −1 |
| Q2 2025 | 16 | -2 | 29.15M | $2.39B | +1 | −3 |
| Q1 2025 | 15 | 0 | 7.80M | $761.04M | — | — |
| Q4 2024 | 15 | 0 | 6.76M | $604.90M | +2 | −2 |
| Q3 2024 | 14 | 0 | 4.84M | $531.32M | +1 | −1 |
| Q2 2024 | 14 | — | 5.72M | $459.02M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.65M | — | $132.58M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.65M | — | $132.58M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.24M | — | $99.61M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.24M | — | $99.61M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 746.85K | — | $59.96M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 746.85K | — | $59.96M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Norges Bank ✦ (passive) | 475.60K | — | $38.19M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 395.77K | — | $31.78M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 395.77K | — | $31.78M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 395.77K | — | $31.78M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 333.72K | — | $26.79M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 302.97K | — | $24.33M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 302.97K | — | $24.33M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 302.97K | — | $24.33M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 215.43K | — | $17.30M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 156.80K | — | $12.59M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 109.13K | — | $8.76M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 33.92K | — | $2.72M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 31.47K | — | $2.53M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 31.47K | — | $2.53M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 15.12K | — | $1.21M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 8.33K | — | $668,494 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 401 holders, 70.59M shares, $5.23B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Aug 13
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Jul 31
SC 13G — VANGUARD PORTFOLIO MANAGEMENT LLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API